Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology

1 · Sector

Weight and 12M allocation change

Consumer Discretionary53.6%+53.57 ppInformation Technology13.3%+13.32 ppHealth Care7.9%+7.89 ppFinancials7.2%+7.19 ppIndustrials6.2%+6.17 ppConsumer Staples3.6%+3.57 ppCommunication Services2.4%+2.43 ppMaterials1.6%+1.59 ppReal Estate1.5%+1.47 ppEnergy1.2%+1.18 ppUtilities1.5%-98.38 pp

2 · Industry

Inside Health Care

Pharmaceuticals2.37%+2.37 ppHealth Care Equipment1.67%+1.66 ppBiotechnology1.11%+1.10 ppLife Sciences Tools & Services0.99%+0.99 ppManaged Health Care0.94%+0.94 ppHealth Care Services0.42%+0.42 ppHealth Care Distributors0.14%+0.14 ppHealth Care Supplies0.14%+0.14 ppHealth Care Facilities0.12%+0.12 ppHealth Care Technology0.00%+0.00 pp

3 · Sub-industry

Inside Biotechnology

Biotechnology1.11%+1.105 pp
Concentrated

Most of this industry's gains came from a few companies.

View all contributions →
Biotechnology · weight
1.11%
Industry change · 12M
+1.10 pp
Biotechnology · contribution
+1.105 pp
Company participation
0%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Feb 2021 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
AbbVie →
ABBV
United States$190.3bn0.380%-0.404 pp+0.380 pp+32.4%No
Amgen →
AMGN
United States$129.9bn0.260%-0.289 pp+0.259 pp+15.8%No
Gilead Sciences →
GILD
United States$77.2bn0.154%-0.169 pp+0.154 pp-7.9%No
Vertex Pharmaceuticals →
VRTX
United States$55.3bn0.110%-0.141 pp+0.110 pp-5.1%No
Regeneron Pharmaceuticals →
REGN
United States$42.3bn0.085%-0.121 pp+0.084 pp+1.3%No
Biogen →
BIIB
United States$41.6bn0.083%-0.074 pp+0.083 pp-11.5%No
Incyte →
INCY
United States$17.3bn0.035%-0.044 pp+0.034 pp+4.3%No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.